European Journal of Cancer
Volume 45, Issue 1 , Pages 127-138, January 2009

Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland

  • Rianne de Gelder

      Affiliations

    • Erasmus MC, Department of Public Health, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel.: +31 10 4638456; fax: +31 10 4638474.
  • ,
  • Jean-Luc Bulliard

      Affiliations

    • Cancer Epidemiology Unit, Institute of Social and Preventive Medicine (IUMSP), University of Lausanne, Switzerland
  • ,
  • Chris de Wolf

      Affiliations

    • Agence Pour le Développement et évaluation des Politiques de Santé, Geneva, Switzerland
  • ,
  • Jacques Fracheboud

      Affiliations

    • Erasmus MC, Department of Public Health, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
  • ,
  • Gerrit Draisma

      Affiliations

    • Erasmus MC, Department of Public Health, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
  • ,
  • Doris Schopper

      Affiliations

    • Swiss Cancer League, Bern, Switzerland
  • ,
  • Harry J. de Koning

      Affiliations

    • Erasmus MC, Department of Public Health, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands

Received 9 July 2008; received in revised form 17 September 2008; accepted 25 September 2008. published online 28 November 2008.

Abstract 

Background

Various centralised mammography screening programmes have shown to reduce breast cancer mortality at reasonable costs. However, mammography screening is not necessarily cost-effective in every situation. Opportunistic screening, the predominant screening modality in several European countries, may under certain circumstances be a cost-effective alternative. In this study, we compared the cost-effectiveness of both screening modalities in Switzerland.

Methods

Using micro-simulation modelling, we predicted the effects and costs of biennial mammography screening for 50–69 years old women between 1999 and 2020, in the Swiss female population aged 30–70 in 1999. A sensitivity analysis on the test sensitivity of opportunistic screening was performed.

Results

Organised mammography screening with an 80% participation rate yielded a breast cancer mortality reduction of 13%. Twenty years after the start of screening, the predicted annual breast cancer mortality was 25% lower than in a situation without screening. The 3% discounted cost-effectiveness ratio of organised mammography screening was €11,512 per life year gained. Opportunistic screening with a similar participation rate was comparably effective, but at twice the costs: €22,671–24,707 per life year gained. This was mainly related to the high costs of opportunistic mammography and frequent use of imaging diagnostics in combination with an opportunistic mammogram.

Conclusion

Although data on the performance of opportunistic screening are limited, both opportunistic and organised mammography screening seem effective in reducing breast cancer mortality in Switzerland. However, for opportunistic screening to become equally cost-effective as organised screening, costs and use of additional diagnostics should be reduced.

Keywords: Breast cancer, Mammography, Mass screening, Opportunistic screening, Cost-benefit analysis, Cost-effectiveness, Breast cancer mortality, Computer simulation, Computer models

 

PII: S0959-8049(08)00747-8

doi:10.1016/j.ejca.2008.09.015

European Journal of Cancer
Volume 45, Issue 1 , Pages 127-138, January 2009